Revance Therapeutics shares owned by Burleson & Company
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Burleson & Company
from 13F filings
Historical chart of Burleson & Company investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Burleson & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Burleson & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-12-31 | $5.9k | 320 | 18.46 |
| 2022-09-30 | $9.0k | 320 | 28.13 |
| 2022-06-30 | $4.0k | 320 | 12.50 |
| 2022-03-31 | $6.0k | 320 | 18.75 |
| 2021-12-31 | $5.0k | 320 | 15.63 |
| 2021-09-30 | $9.0k | 320 | 28.13 |
| 2021-06-30 | $9.0k | 320 | 28.13 |
| 2021-03-31 | $9.0k | 320 | 28.13 |